Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population
27 August 2018 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Bristol-Myers Squibb, Lawrenceville (United States of America)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2018
27 August 2018
14:00 CET
You may be interested in
Webinar
